BPL bets on critical care, imaging to quadruple revenue to ₹2,000 crore by 2032

Critical care already contributes more than half of BPL’s revenue, while imaging and acquisitions are expected to strengthen its expansion
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns BPL (BPL).
- Category: Orders & Deals.
Why it matters
A routine update for BPL. Use the price and stock snapshot to gauge how the market is responding.












